Stevenson Search Partners is pleased to announce the appointment of Jay Cross, MPH to Chief Financial Officer of Senti Biosciences.
Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for patients living with incurable diseases. To achieve this, Senti Bio is leveraging a synthetic biology platform called Gene Circuits to create therapies with enhanced precision and control.
Prior to joining Senti Bio, Mr. Cross spent six years as Chief Financial Officer at Sonnet BioTherapeutics, where he directed a successful capital markets campaign that yielded over $100 million in investment capital. As a complement to his corporate experience, Mr. Cross enjoyed a 20-year career on Wall Street, where he served as a managing director in the healthcare investment banking practice at Chardan, in addition to working as a professional investor on globally diversified healthcare portfolios at several funds, including SAC Capital, Citadel, and Balyasny Asset Management. Mr. Cross launched his career in finance covering biotechnology for the equity research divisions at Hambrecht & Quist and Goldman Sachs.
Mr. Cross earned a Master of Public Health from the Yale University School of Medicine and a Bachelor of Science in Psychology from Washington & Lee University.
About Stevenson Search Partners
Stevenson Search Partners is a global life sciences executive search firm with over 40 years of experience, specializing in building executive teams for biotech, pharma, MedTech, HealthTech, and CRO/CDMO sectors. They offer a range of services including executive search, on-demand talent solutions, board advisory, talent-mapping, and executive coaching, providing tailored solutions to support clients across the life sciences value chain. Stevenson's approach is collaborative and client-centered, focusing on finding leaders who drive innovation in the industry.
